Edinburgh Research Explorer Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer

[1]  Rodney J Scott,et al.  Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial , 2011, The Lancet.

[2]  R. Lau,et al.  Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies , 2011, BMJ : British Medical Journal.

[3]  D. Bishop,et al.  A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis , 2011, Cancer Prevention Research.

[4]  Peter M. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomized trials , 2011 .

[5]  R. Kucherlapati,et al.  Aspirin and Low-Dose Nitric Oxide–Donating Aspirin Increase Life Span in a Lynch Syndrome Mouse Model , 2011, Cancer Prevention Research.

[6]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[7]  A. Algra,et al.  Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials , 2010, The Lancet.

[8]  J. Mathers,et al.  Differential Antineoplastic Effects of Butyrate in Cells With and Without a Functioning DNA Mismatch Repair , 2009, Nutrition and cancer.

[9]  M. Thun,et al.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. , 2009, The Lancet. Oncology.

[10]  Ying Hu,et al.  Effect of high amylose maize starches on colonic fermentation and apoptotic response to DNA-damage in the colon of rats , 2009, Nutrition & metabolism.

[11]  J. Baron,et al.  Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. , 2009, Journal of the National Cancer Institute.

[12]  S. Manekeller.  Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome , 2009 .

[13]  D. Bishop,et al.  Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. , 2008, The New England journal of medicine.

[14]  J. Mathers,et al.  Cell kinetics and gene expression changes in colorectal cancer patients given resistant starch: a randomised controlled trial , 2008, Gut.

[15]  L. Cobiac,et al.  Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats , 2008, Carcinogenesis.

[16]  D. Bishop,et al.  Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  A. Sartorelli,et al.  Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk? , 2008, Cell cycle.

[18]  M. Glade.  Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective, World Cancer Research Fund/American Institute for Cancer Research. American Institute for Cancer Research, Washington, D.C (2007), ISBN: 978-0-9722522-2-5 , 2008 .

[19]  L. Kopelovich,et al.  Nitric oxide-donating aspirin derivatives suppress microsatellite instability in mismatch repair-deficient and hereditary nonpolyposis colorectal cancer cells. , 2007, Cancer research.

[20]  Shuji Ogino,et al.  Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.

[21]  P. Rothwell,et al.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.

[22]  P. Møller,et al.  Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) , 2007, Journal of Medical Genetics.

[23]  A. Esterman,et al.  Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats. , 2006, Carcinogenesis.

[24]  E. Riboli,et al.  The second expert report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2007 .

[25]  H. Glatt,et al.  Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon. , 2006, Carcinogenesis.

[26]  A. Watson.  An overview of apoptosis and the prevention of colorectal cancer. , 2006, Critical reviews in oncology/hematology.

[27]  W. Willett,et al.  Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. , 2005, JAMA.

[28]  T. Kunkel,et al.  DNA mismatch repair. , 2005, Annual review of biochemistry.

[29]  F. Nagengast,et al.  Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation , 1994, Digestive Diseases and Sciences.

[30]  C. Lao,et al.  Strategies for prevention of colorectal cancer: Pharmaceutical and nutritional interventions , 2004, Current treatment options in oncology.

[31]  J. Mathers,et al.  Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms , 2003, Proceedings of the Nutrition Society.

[32]  B. Leggett,et al.  Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. , 2002, European journal of cancer.

[33]  R. Goodlad,et al.  Redefining dietary fibre: potentially a recipe for disaster , 2001, The Lancet.

[34]  P. Clifton,et al.  Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. , 2001, Physiological reviews.

[35]  J. Faivre,et al.  Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial , 2000, The Lancet.

[36]  D. Alberts,et al.  Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. , 2000, The New England journal of medicine.

[37]  T. Byers.  Diet, colorectal adenomas, and colorectal cancer. , 2000, The New England journal of medicine.

[38]  J. Weissfeld,et al.  Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. , 2000, The New England journal of medicine.

[39]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[40]  J. Mathers,et al.  Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months. , 1999, Carcinogenesis.

[41]  J. Rüschoff,et al.  Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Deurenberg,et al.  Limited effect of consumption of uncooked (RS2) or retrograded (RS3) resistant starch on putative risk factors for colon cancer in healthy men. , 1998, The American journal of clinical nutrition.

[43]  A. Gostner,et al.  Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention. , 1998, The American journal of clinical nutrition.

[44]  J. Mathers,et al.  Dose–response effects of raw potato starch on small-intestinal escape, large-bowel fermentation and gut transit time in the rat , 1997, British Journal of Nutrition.

[45]  J. Hautvast,et al.  Nutritional Implications Of Resistant Starch , 1996, Nutrition Research Reviews.

[46]  J. Jass,et al.  Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? , 1995, Seminars in surgical oncology.

[47]  D. Morgan,et al.  Intake of carbohydrate and its components--international comparisons, trends over time, and effects of changing to low-fat diets. , 1995, The American journal of clinical nutrition.

[48]  W C Willett,et al.  Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.

[49]  W. R. Bruce,et al.  A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. Toronto Polyp Prevention Group. , 1994, Journal of clinical epidemiology.

[50]  S. Bingham,et al.  Starch intake and colorectal cancer risk: an international comparison. , 1994, British Journal of Cancer.